UINF:F:F-Multi Units Luxembourg - Lyxor US$ 10Y Inflation Breakeven UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 119.355

Change

0.00 (0.00)%

Market Cap

USD 0.21B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.74 (+2.78%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.29 (+2.56%)

USD 109.59B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.80 (-0.33%)

USD 96.22B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.47 (+2.68%)

USD 91.00B
SXRZ:F iShares VII PLC - iShares Nikk..

+6.60 (+2.79%)

USD 54.70B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.24 (+1.55%)

USD 52.21B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.04 (-0.52%)

USD 40.38B
0ZC:F Zscaler Inc

+1.02 (+0.66%)

USD 37.92B

ETFs Containing UINF:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.18% 57% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.18% 55% F 56% F
Trailing 12 Months  
Capital Gain 8.25% 54% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.25% 52% F 55% F
Trailing 5 Years  
Capital Gain 30.19% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.19% 54% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 6.24% 65% D 65% D
Dividend Return 6.24% 63% D 59% D-
Total Return N/A 71% C- 95% A
Risk Return Profile  
Volatility (Standard Deviation) 10.11% 62% D 84% B
Risk Adjusted Return 61.71% 82% B 85% B
Market Capitalization 0.21B 42% F 39% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.